Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Biohaven Ltd.

Biohaven Ltd. (BHVN) Stock Overview

Explore Biohaven Ltd.’s financial performance, market position, analyst ratings, and future outlook.

BHVN●NYSE
HealthcareBiotechnology
$14.22
$0.60(4.41%)
U.S. Market opens in 8h 29m

Biohaven Ltd. (BHVN)

Meyka AI Score

Z

Key Financials

Market Cap2.1B
P/E Ratio-3.02
EPS (TTM)$-4.64
ROE-13.29%
Fundamental Analysis

AI Price Forecasts

1 Month$14.99
3 Months$19.36
1 Year Target$1.81

BHVN Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Biohaven Ltd. (NYSE: BHVN) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Biohaven Ltd.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of BHVN on the NYSE shows an RSI of 50.50, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $1.81 for the NYSE listing.

Key metrics behind Biohaven Ltd.'s NYSE-traded stock include a P/E ratio of -3.02 and a market capitalization of 2.1B. Combined with our AI analysis, these give both institutional and retail investors a clear view of BHVN on the NYSE.

Price Performance (NYSE: BHVN)

1-Day Change
4.33%
5-Day Change
15.15%
1-Month Change
2.60%
3-Month Change
-8.32%
6-Month Change
59.13%
Year-to-Date (YTD) Change
25.86%
1-Year Change
-4.31%
3-Year Change
-17.34%
5-Year Change
94.66%
All-Time (Max) Change
94.66%

Contact Information

https://www.biohaven.com
203 404 0410
215 Church Street, New Haven, CT, 06510

Company Facts

2,740 Employees
IPO DateSep 23, 2022
CountryUS
Actively Trading

Frequently Asked Questions